NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce the release of its scheduled pre-recorded webcast audio conference. The pre-recorded webcast audio conference, updates shareholders on the Company’s strategy and reports on the way forward toward clinical trials.
